---
title: "Aktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293257302.md"
description: "Aktis Oncology director Ken Herrmann sold 3,065 common shares on July 17, 2026, at approximately $25.21 per share, totaling $77,279.54. He simultaneously exercised stock options for the same number of shares at $0.08 each. Following these transactions, Herrmann reported owning zero common shares directly."
datetime: "2026-07-20T21:35:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293257302.md)
  - [en](https://longbridge.com/en/news/293257302.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293257302.md)
generator: "portal-rs"
---

# Aktis Oncology director Ken Herrmann disposes of 3,065 common shares worth $77,279.54

-   Aktis Oncology director Ken Herrmann sold 3,065 common shares on July 17, 2026 at about $25.21 per share. \* He exercised stock options for 3,065 shares the same day at $0.08 per share. \* Post-transaction, he reported 0 common shares owned directly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aktis Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-309115), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [AKTS.US](https://longbridge.com/en/quote/AKTS.US.md)

## Related News & Research

- [Aktis Oncology director Ken Herrmann disposes of common shares worth $119,256.78](https://longbridge.com/en/news/293400552.md)
- [Aktis Oncology CMO Akos Czibere disposes of common shares worth $1.29 million](https://longbridge.com/en/news/292305354.md)
- [Better founder Vishal Garg seeks written consents to oust five directors, regain control of board](https://longbridge.com/en/news/297319086.md)
- [09:03 ETNexusOne triples its business in 2026, names Ken Pickering SVP of Engineering to scale the AI & Data Control Plane](https://longbridge.com/en/news/297329981.md)
- [Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027](https://longbridge.com/en/news/296747520.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**